InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Betashares Global Healthcare ETF - Currency Hedged (DRUG)
  6. Company Announcements

Betashares Global Healthcare ETF - Currency Hedged (ASX: DRUG) - Announcements

- Current share price for DRUG : $8.530

Betashares Global Healthcare ETF - Currency Hedged (DRUG) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

Latest company announcements for Betashares Global Healthcare ETF - Currency Hedged (DRUG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$192 Units on Issue Disclosure - Aug 2021 6 Sep 2021 11:57AM $7.960 $8.530 risen by 7.16%
$192 Units on Issue Disclosure - Jul 2021 5 Aug 2021 12:54PM $7.790 $8.530 risen by 9.50%
$192 Estimated Annual Distribution Component Information 15 Jul 2021 8:03AM $7.530 $8.530 risen by 13.28%
$192 Units on Issue Disclosure - Jun 2021 6 Jul 2021 3:35PM $7.470 $8.530 risen by 14.19%
$192 DRP Issue Price 1 Jul 2021 5:20PM $7.460 $8.530 risen by 14.34%
$192 Final Distribution Announcement 1 Jul 2021 8:11AM $7.760 $8.530 risen by 9.92%
$192 Estimated Distribution Announcement 29 Jun 2021 6:57PM $7.730 $8.530 risen by 10.35%
$192 Distribution Timetable 24 Jun 2021 6:09PM $7.650 $8.530 risen by 11.50%
$192 Units on Issue Disclosure - May 2021 4 Jun 2021 9:41AM $7.360 $8.530 risen by 15.90%
$192 Units on Issue Disclosure - Apr 2021 6 May 2021 4:32PM $7.380 $8.530 risen by 15.58%
$192 Units on Issue Disclosure - Mar 2021 6 Apr 2021 3:49PM $7.130 $8.530 risen by 19.64%
$192 Indicative 2021 Distributions Calendar 10 Feb 2021 9:03AM $7.080 $8.530 risen by 20.48%
$192 Units on Issue Disclosure - Jan 2021 4 Feb 2021 11:51AM $7.030 $8.530 risen by 21.34%
$192 Estimated Distribution Component Information 12 Jan 2021 8:19AM $7.090 $8.530 risen by 20.31%
$192 Units on Issue Disclosure - Dec 2020 6 Jan 2021 3:25PM $6.920 $8.530 risen by 23.27%
$192 DRP Issue Price 5 Jan 2021 8:24AM $6.990 $8.530 risen by 22.03%
$192 Final Distribution Announcement 4 Jan 2021 8:18AM $6.930 $8.530 risen by 23.09%
$192 Estimated Distribution Announcement 30 Dec 2020 6:34PM $6.960 $8.530 risen by 22.56%
$192 Distribution Timetable 23 Dec 2020 5:23PM $6.860 $8.530 risen by 24.34%
$192 Units on Issue Disclosure - Nov 2020 4 Dec 2020 3:55PM $6.880 $8.530 risen by 23.98%
$192 Units on Issue Disclosure - Oct 2020 5 Nov 2020 11:15AM $6.740 $8.530 risen by 26.56%
$192 Units on Issue Disclosure - Sep 2020 6 Oct 2020 1:42PM $6.700 $8.530 risen by 27.31%
$192 Annual Financial Report 28 Sep 2020 2:17PM $6.620 $8.530 risen by 28.85%
$192 Units on Issue Disclosure - Aug 2020 4 Sep 2020 10:36AM $6.680 $8.530 risen by 27.69%
$192 Units on Issue Disclosure - July 2020 6 Aug 2020 1:23PM $6.670 $8.530 risen by 27.89%

76 - 100 of 122 results

Page 4 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.